Fiji vs Serbia: Cause of death, by non-communicable diseases, ages 15-59, male
Fiji
63.7%
in 2021
Serbia
63.8%
in 2021
Fiji rank
51st
Serbia rank
48th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Fiji
- Serbia
How they compare
Serbia currently reports 63.8% against 63.7% in Fiji, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Serbia ahead.
Fiji ranks 51st and Serbia ranks 48th of 185 countries.
Across the 3 decades both report, Fiji averaged higher in 1 and Serbia in 2.
Head to head by decade
| Decade | Fiji | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 78.9% | 79.5% | 0.6% | Serbia |
| 2010s | 81.3% | 83.7% | 2.5% | Serbia |
| 2020s | 72.6% | 67.8% | 4.8% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Fiji or Serbia?
- Serbia, at 63.8% against 63.7% in Fiji as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Fiji and Serbia?
- 0.1%, with Serbia ahead.
- How many years of comparable data are there for Fiji and Serbia?
- 6 years are reported by both, from 2000 to 2021.
- How do Fiji and Serbia rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Fiji ranks 51st and Serbia ranks 48th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.